MYC in Mature B-Cell Acute Lymphoblastic Leukemia
المؤلف:
Hoffman, R., Benz, E. J., Silberstein, L. E., Heslop, H., Weitz, J., & Salama, M. E.
المصدر:
Hematology : Basic Principles and Practice
الجزء والصفحة:
8th E , P1051
2026-11-19
25
The vast majority of cases of mature B-cell ALL (Burkitt leukemia) are characterized by a translocation that places one allele of MYC from chromosome 8 under the control of the regulatory elements of an Ig gene, either the heavy-chain gene on chromosome 14q32 or the κ or λ light-chain genes on chromosomes 2 and 22, respectively. These translocations are oncogenic because they result in lineage specific overexpression of MYC, a prototypical basic helix–loop helix oncogenic transcription factor. The mechanisms through which MYC exerts its potent oncogenic effects have been the subject of intense investigation. MYC has been estimated to regulate the expression of 15% of the genome and leads to the transcriptional activation of a large number of genes involved in cell division, growth, metabolism, adhesion, and motility. MYC also exerts post transcriptional effects on gene expression by regulating microRNA expression and ribosome biogenesis. MYC exerts its transcriptional activity via the formation of heterodimers with its DNA-binding partner protein MAX. MYC–MAX heterodimers bind to canonical hexameric E-box DNA sequences (5′-CACGTG-3′) where they activate transcription. MAX can also heterodimerize with other bHLH proteins, including MAD, MXI-1 (MAD2), and MNT. Whereas transcriptional activation by MYC–MAX complexes pro motes proliferation, binding by MAD–MAX and other MAX het erodimers produces opposite effects. For example, MAD inhibits MYC function both by competing with MYC for binding to MAX and by directly inhibiting transcription.
Recent work has revealed that a major consequence of MYC overexpression is the global amplification of gene expression. Investigation of transcriptional regulation mechanisms has revealed two distinct steps in the regulation of gene expression by transcription factors. First, RNA polymerase II and its associated transcriptional apparatus are loaded onto a gene promoter by one set of transcription factors, but RNA polymerase is often initially “paused” near the proximal promoter. Subsequent release from transcriptional pause is a distinct and highly regulated step in the control of gene expression. Unexpectedly, recent studies have revealed that a major consequence of MYC overexpression is the release of transcriptional pause at genes that were already loaded with RNA polymerase, rather than the recruitment of RNA polymerase to new target genes. These findings support a model in which MYC overexpression functions to amplify the expression of genes that are already being transcribed, thus “locking in” a cell’s existing transcriptional program. The acquisition of an MYC-activating lesion in a cell with a highly proliferative gene expression program that is normally transient, such as an immature B-cell progenitor, can lock this cell in this highly proliferative state, thus providing one mechanism to explain MYC-driven oncogenesis.
0
0
الاكثر قراءة في الاورام
اخر الاخبار
اخبار العتبة العباسية المقدسة